Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan J Feld

Showing results (191-200 of 333) with videos related to

Pageof 34
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 23, 2023
Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET studyWesam Aleyadeh, Elizabeth C Verna, Hany Elbeshbeshy, et al.
Hepatology (Baltimore, Md.)|September 19, 2021
The viral hepatitis B care cascade: A population-based comparison of immigrant groupsAbdool S Yasseen, Jeffrey C Kwong, Jordan J Feld, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2021
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian RegistryFernanda Q Onofrio, Curtis Cooper, Sergio M Borgia, et al.
Journal of Virological Methods|April 1, 2017
HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patientsJürgen Kurt Rockstroh, Jordan J Feld, Stéphane Chevaliez, et al.
BMC Infectious Diseases|June 2, 2016
HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infectionFrançois M J Lamoury, Behzad Hajarizadeh, Elizabeth Keoshkerian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2017
Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment CessationHeng Chi, David Wong, Jie Peng, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trialTarik Asselah, Christophe Hézode, Roula B Qaqish, et al.
American Journal of Hematology|July 6, 2013
Liver stiffness increases acutely during sickle cell vaso-occlusive crisisChristopher Koh, Tiffany Turner, Xiongce Zhao, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|August 27, 2025
National hepatitis B and C estimates for 2021: Measuring Canada's progress towards eliminating viral hepatitis as a public health concernSimone Périnet, Anson Williams, Laurence Campeau, et al.
Cytokine|June 18, 2018
IL-15 and IFN-γ signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signalingFatemeh Vahedi, Amanda J Lee, Susan E Collins, et al.
Pageof 34

Showing results (191-200 of 333) with videos related to

Sort By:
Pageof 34
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 23, 2023
Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET studyWesam Aleyadeh, Elizabeth C Verna, Hany Elbeshbeshy, et al.
Hepatology (Baltimore, Md.)|September 19, 2021
The viral hepatitis B care cascade: A population-based comparison of immigrant groupsAbdool S Yasseen, Jeffrey C Kwong, Jordan J Feld, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2021
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian RegistryFernanda Q Onofrio, Curtis Cooper, Sergio M Borgia, et al.
Journal of Virological Methods|April 1, 2017
HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patientsJürgen Kurt Rockstroh, Jordan J Feld, Stéphane Chevaliez, et al.
BMC Infectious Diseases|June 2, 2016
HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infectionFrançois M J Lamoury, Behzad Hajarizadeh, Elizabeth Keoshkerian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2017
Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment CessationHeng Chi, David Wong, Jie Peng, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trialTarik Asselah, Christophe Hézode, Roula B Qaqish, et al.
American Journal of Hematology|July 6, 2013
Liver stiffness increases acutely during sickle cell vaso-occlusive crisisChristopher Koh, Tiffany Turner, Xiongce Zhao, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|August 27, 2025
National hepatitis B and C estimates for 2021: Measuring Canada's progress towards eliminating viral hepatitis as a public health concernSimone Périnet, Anson Williams, Laurence Campeau, et al.
Cytokine|June 18, 2018
IL-15 and IFN-γ signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signalingFatemeh Vahedi, Amanda J Lee, Susan E Collins, et al.
Pageof 34